NZD35.50
2.47%
New Zealand Exchange, Fri, Sep 27 2024
ISIN
NZFAPE0001S2
Symbol
FPH
Sector

Fisher & Paykel Healthcare Corporation Stock price

NZD35.50
+0.28 0.80% 1M
+9.12 34.55% 6M
+11.93 50.63% YTD
+13.67 62.62% 1Y
+3.66 11.49% 3Y
+18.91 113.96% 5Y
+30.39 595.27% 10Y
New Zealand Exchange, Closing price Fri, Sep 27 2024
-0.90 2.47%
ISIN
NZFAPE0001S2
Symbol
FPH
Sector

Key metrics

Market capitalization NZD21.33b
Enterprise Value NZD21.44b
P/E (TTM) P/E ratio 159.51
EV/FCF (TTM) EV/FCF 190.09
EV/Sales (TTM) EV/Sales 12.20
P/S ratio (TTM) P/S ratio 12.14
P/B ratio (TTM) P/B ratio 12.07
Dividend yield 1.56%
Last dividend (FY24) NZD0.64
Revenue growth (TTM) Revenue growth 10.67%
Revenue (TTM) Revenue NZD1.76b
EBIT (operating result TTM) EBIT NZD368.70m
Free Cash Flow (TTM) Free Cash Flow NZD112.80m
EPS (TTM) EPS NZD0.23
P/E forward 59.27
P/S forward 10.69
EV/Sales forward 10.75
Show more

Is Fisher & Paykel Healthcare Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Fisher & Paykel Healthcare Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Fisher & Paykel Healthcare Corporation forecast:

2x Buy
13%
9x Hold
56%
5x Sell
31%

Analyst Opinions

16 Analysts have issued a Fisher & Paykel Healthcare Corporation forecast:

Buy
13%
Hold
56%
Sell
31%

Financial data from Fisher & Paykel Healthcare Corporation

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Mar '24
+/-
%
1,758 1,758
11% 11%
100%
- Direct Costs 698 698
9% 9%
40%
1,060 1,060
12% 12%
60%
- Selling and Administrative Expenses 379 379
14% 14%
22%
- Research and Development Expense 198 198
14% 14%
11%
483 483
10% 10%
27%
- Depreciation and Amortization 114 114
15% 15%
7%
EBIT (Operating Income) EBIT 369 369
9% 9%
21%
Net Profit 133 133
47% 47%
8%

In millions NZD.

Don't miss a Thing! We will send you all news about Fisher & Paykel Healthcare Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Fisher & Paykel Healthcare Corp. Ltd. engages in the designing, manufacturing and marketing of medical device products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. It operates through the following geographical segments: The New Zealand, North America, Europe, and Asia-Pacific. The New Zealand segment includes all activities controlled by entities or employees based in New Zealand, principally research and development, manufacturing, marketing, sales and distribution and administration. The North America segment refers to all activities controlled by entities or employees based in the United States of America and Canada, principally sales, distribution and administration activities. The Europe segment includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, principally sales, distribution and administration activities. The Asia-Pacific segment refers to all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, principally sales, distribution and administration activities. The company was founded in 1934 and is headquartered in Auckland, New Zealand.

Head office New Zealand
CEO Lewis Gradon
Employees 7,141
Founded 1934
Website www.fphcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today